GW Pharmaceuticals Plc (GWP) - Medical Equipment - Deals and Alliances Profile

GlobalData
25 Pages - GLDATA61906
$250.00

Summary

GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the treatment of spasticity due to multiple sclerosis. It sells and distributes the product through strategic collaborations with other pharmaceutical companies. GW Pharmaceuticals is also developing other products that are focused at treating Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis, infantile spasms, epilepsy, glioma, schizophrenia, autism among others. The company along with its subsidiaries operates in the US, England and Wales. GW Pharmaceuticals is headquartered in Cambridgeshire, the UK.

GW Pharmaceuticals Plc (GWP) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
GW Pharmaceuticals Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
GW Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
GW Pharmaceuticals Plc, Medical Equipment, Deal Details 10
Private Equity 10
Mentor Capital Invests USD1 Million in GW Pharma 10
Equity Offering 11
GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 11
GW Pharma Completes Public Offering Of American Depositary Shares For US$101 Million 12
Acquisition 13
GW Pharma May Sell Itself 13
GW Pharmaceuticals Plc - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Feb 07, 2017: GW Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Progress 18
Dec 05, 2016: GW Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress 20
Aug 09, 2016: GW Pharmaceuticals Reports Third Quarter 2016 Financial Results and Operational Progress 21
May 05, 2016: GW Pharmaceuticals Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress 22
Feb 10, 2016: GW Pharmaceuticals Reports First Quarter 2016 Financial Results and Operational Progress 23
Corporate Communications 24
Mar 07, 2017: GW Pharmaceuticals Announces the Appointment of Scott Giacobello as Chief Financial Officer and Adam George as Managing Director - UK 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
GW Pharmaceuticals Plc, Medical Equipment, Key Facts, 2016 1
GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
GW Pharmaceuticals Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
GW Pharmaceuticals Plc, Deals By Market, 2011 to YTD 2017 8
GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Mentor Capital Invests USD1 Million in GW Pharma 10
GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 11
GW Pharma Completes Public Offering Of American Depositary Shares For US$101 Million 12
GW Pharma May Sell Itself 13
GW Pharmaceuticals Plc, Key Competitors 15
GW Pharmaceuticals Plc, Key Employees 16
GW Pharmaceuticals Plc, Other Locations 17
GW Pharmaceuticals Plc, Subsidiaries 17

List of Figures
GW Pharmaceuticals Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
GW Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
GW Pharmaceuticals Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
GW Pharmaceuticals Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838